Lindsay A. Rosenwald M.D., Director at Journey Medical Corp (DERM), bought 20,000 shares at $3.40 ($68K) on 2024-03-22, disclosed to the SEC on 2024-03-25.
Open-market purchase of $68k DERM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| FBIO | BUY | 2024-05-20 | $18K | — | Filing → |
| DERM | BUY | 2024-03-27 | $30K | — | Filing → |
| FBIO | BUY | 2024-01-09 | $119K | — | Filing → |